Dr Reddy's Laboratories Ltd
SWB:RDDA
Relative Value
The Relative Value of one
RDDA
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 12.4 EUR,
Dr Reddy's Laboratories Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
RDDA Competitors Multiples
Dr Reddy's Laboratories Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Dr Reddy's Laboratories Ltd
SWB:RDDA
|
1.1T EUR | 3.1 | 19.4 | 12.4 | 16.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
993.5B USD | 15.2 | 48.1 | 32.4 | 34.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
590.8B USD | 6.3 | 22 | 15.3 | 18.8 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
298B CHF | 4.9 | 31.7 | 13.3 | 15.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
239.4B GBP | 5.6 | 32 | 17.6 | 24.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
246.7B CHF | 5.6 | 22.7 | 14 | 17.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
307.1B USD | 4.7 | 16.8 | 10.5 | 12.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.5 | 10.6 | 7.9 | 9.2 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.9B USD | 2.5 | 19.8 | 7.4 | 9.9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.1B USD | 2.6 | 17.5 | 7.3 | 9 |